PCRX
Pacira BioSciences, Inc.
Pacira BioSciences, Inc. (PCRX) has 13 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 13, 2026.
The most active filer is Chief Financial Officer Cross Shawn with 4 filings. Insiders have net sold $1.0M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Frank D. Lee
- Employees:788
- HQ:Tampa, FL, US
- IPO:2011-02-03
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$1.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
RIKER LAURENFirst filing | Senior Vice President, Finance | Sale | 6,115 | $144K | Jun 13 | SEC ↗ |
WILLIAMS KRISTENFirst filing | Chief Administrative Officer | Sale | 10,259 | $228K | Jun 5 | SEC ↗ |
| Chief Financial Officer | Sale | 12,941 | $326K | Apr 25 | SEC ↗ | |
Cross ShawnFirst filing | Chief Financial Officer | Sale | 7,714 | $194K | Apr 22 | SEC ↗ |
Cross ShawnFirst filing | Chief Financial Officer | Sale | 2,845 | $71K | Apr 22 | SEC ↗ |
Cross ShawnFirst filing | Chief Financial Officer | Sale | 1,500 | $38K | Apr 22 | SEC ↗ |
Related companies
Pacira BioSciences, Inc. is in the Healthcare sector.